Pharmafile Logo

Spanish reimbursement system

Roche Basel Switzerland

Another IO knockback as Tecentriq combo fails phase III trial

The bulk of CRC patients with MSS currently look set to be excluded from cancer immunotherapy

- PMLiVE

AZ’s Fasenra hit by COPD trial failure

Results give advantage to respiratory rivals GSK

- PMLiVE

Despite FDA concerns, Akcea rare disease drug clears FDA panel

FDA now set to deliver final verdict by 30 August

- PMLiVE

Cognite appoints Vee Ragunathan

She joins the agency from Publicis Resolute

- PMLiVE

Ashfield welcomes second intake of medical writers

New recruits join the programme

- PMLiVE

How Augmented reality is disrupting healthcare

Augmented reality (AR) gained widespread attention in the summer of 2016 with the addictive game, Pokémon Go. But these days, AR is not just for fun. This disruptive technology is...

Eli Lilly HQ

Lilly buys Armo for $1.6bn to bolster immuno-oncology pipeline

Armo is developing IL-10 drugs for potential combination with established immunotherapies

PEGASUS PHARMA TEAM GOES FROM STRENGTH TO STRENGTH WITH NEW APPOINTMENTS AND SENIOR PROMOTIONS

Growth trend continues at Pegasus with six new appointments and five promotions in the Pharma and Life Sciences team

Inizio

- PMLiVE

Sir Bruce Keogh is appointed chair of judges for HSJ Awards

Sir Bruce Keogh, the former National Medical Director for NHS England, will chair the judges’ panel for the 37th annual HSJ Awards – the world’s largest healthcare awards programme.

Wilmington Healthcare

- PMLiVE

Daily Brief

A rapid round-up of the top pharma, biotech and healthcare news

- PMLiVE

Cancer in The Information Age: are we illuminated or inundated?

Is cancer becoming too complicated, too interconnected, for human understanding alone?

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links